Peripheral Intervention Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Peripheral Intervention Market
Peripheral Intervention Market: By Type (Angioplasty Procedures. Angioplasty Stents, Others), By Procedure (Angioplasty Stents, Angioplasty Balloons, IVC Filters, Others) & By Region-Forecast (2016-2021)
Report Code : HCR 0305
Updated Date: 25 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Peripheral intervention surgeries are done to address the root cause of peripheral artery disease, by remove plaques, and others.  They are part of the minimal invasive surgeries for restoring the flow of blood to the other part of the arteries where the blood clot prevented the flow of oxygenated blood. Globally, development of efficient and advance technology, rise in the awareness among people regarding peripheral artery diseases and coronary diseases, increasing government initiative across the globe, growing demand for minimal invasive and non-invasive surgical procedures are the prime growth drivers of global peripheral intervention market. In addition, increase in adoption of peripheral intervention for peripheral artery diseases, and emerging economies such as China, India and others, will create new opportunities for global peripheral intervention market. However, higher cost of the research and development, and higher cost of interventional devices are the key restraints for global peripheral intervention market.

 Peripheral Intervention Market

Geographically North America dominated global peripheral intervention market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the procedures, oncology procedures has the highest market share in global peripheral intervention market due to higher prevalence of cancer patients.

This report identifies the global peripheral intervention market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global peripheral intervention market.

This report segments global peripheral intervention market on the basis of type, procedures, and regional market as follows:
  • Peripheral Intervention Market, By Type: Angioplasty Procedures. Angioplasty Stents, Angioplasty Balloons, IVC Filters, EVAR Stent Grafts, Assessory Devices, Catheters, Plaque Modification Device, and Hemodynamic Flow Alteration Devices
  • The report has focused study on peripheral intervention market by basis of end-user such as: Vascular, Oncology Procedures, Neurology, Hepatic, Uteral, Renal, Gastric, and Skin Procedures
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the peripheral intervention market. Some of the major companies’ profiles in detail are as follows:
  • W.L.Gore & Associates Ltd.
  • Terumo Interventional Systems Inc.
  • Boston Scientific Corporation
  • C.R. Bard Inc.
  • St. Jude Medical
1. Peripheral Intervention Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Peripheral Intervention Market– Market Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Growing demand for minimal invasive and non-invasive surgical procedures
   4.2. Restraints
      4.2.1. Higher cost of interventional devices
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Peripheral Intervention Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Peripheral Intervention Market, By Type
   6.1. Angioplasty Procedures
   6.2. Angioplasty Stents
   6.3. Angioplasty Balloons
   6.4. IVC Filters
   6.5. EVAR Stent Grafts
   6.6. Assessory Devices
   6.7. Catheters
   6.8. Plaque Modification Device
   6.9. Hemodynamic Flow Alteration Devices
7. Peripheral Intervention Market, By Procedures
   7.1. Vascular
   7.2. Oncology Procedures
   7.3. Neurology
   7.4. Hepatic
   7.5. Uteral
   7.6. Renal
   7.7. Gastric
   7.8. Skin Procedures
8. Peripheral Intervention Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Peripheral Intervention – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. W.L.Gore & Associates Ltd.
   10.2. Terumo Interventional Systems Inc.
   10.3. Boston Scientific Corporation
   10.4. C.R. Bard Inc.
   10.5. St. Jude Medical
   10.6. Cook Medical
   10.7. Medtronic Inc.
   10.8. Volcano Corporation
   10.9. Abbott Vascular
   10.10. Angioscore Ltd.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports